Ind-Swift Laboratories planning to raise funds through NCDs

12 Jun 2018 Evaluate

Ind-Swift Laboratories is planning to raise funds through allotment of Non-Convertible Debentures (NCDs) to the prospective allottees on private placement basis through EBP Mechanism. The meeting of the Board of Directors of the company will be held on June 13, 2018, to consider the same.

Ind-Swift Laboratories has manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry.

Ind-Swift Lab. Share Price

127.65 5.55 (4.55%)
27-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.25
Dr. Reddys Lab 6241.60
Cipla 1480.95
Zydus Lifesciences 1063.45
Lupin 1584.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.